Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Heala Ventures, also known as Sanara Capital, is a health-tech venture capital fund established in 2023 and based in Israel. The firm focuses on Series A and B financing rounds for Israeli-related startups, both domestically and internationally. It is a follow-on fund of Sanara Ventures, which has been operational since 2015 and is backed by industry leaders Philips and Teva.
Heala Ventures invests in health technology sectors, specifically targeting Digital Health, Bio-Convergence, and Medical Devices. The fund primarily engages in Series A and B financing rounds, supporting startups that are innovating in these areas.
Notable portfolio companies include NanoDrops, which develops technology for visual optical correction; CVaid Medical, focusing on AI-based diagnostic tools for early stroke detection; Lydus Medical, innovating in automated microvascular anastomosis; and QLog, providing a digital platform to enhance operational readiness in healthcare facilities.
Submit through their form at sanaraventures.com.
Heala Ventures typically participates in leading financing rounds, particularly in Series A and B stages.
The firm is open to follow-on investments, especially in companies that demonstrate significant growth potential and align with their focus areas.
Specific fund size details are not disclosed, but Heala Ventures has nearly 20 active portfolio companies across both its fund and its predecessor.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.